Evidence map›Paper›PMID 39665829›Full record

ArticleThe Journal of experimental medicine2025

Dual role of vascular endothelial growth factor-C in post-stroke recovery.

Yun Hwa Choi, Martin Hsu, Collin Laaker, Jenna Port, Kristóf G Kovács, Melinda Herbath, Heeyoon Yang, Peter Cismaru, Alexis M Johnson, Bailey Spellman and 3 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The cribriform plate: A dynamic central nervous system-immune hub.The Journal of experimental medicine · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yun Hwa ChoiDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-9344-6110
Martin Hsu *Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-1210-6497
Collin Laaker *Neuroscience Training Program, University of Wisconsin-Madison , Madison, WI, USA.ORCID 0000-0001-8532-9427
Jenna PortDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-5968-7626
Kristóf G KovácsDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-9576-641X
Melinda HerbathDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-8403-582X
Heeyoon YangCollege of Agricultural and Life Sciences, University of Wisconsin-Madison , Madison, WI, USA.ORCID 0009-0009-2213-4433
Peter CismaruDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-9541-2846
Alexis M JohnsonDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0003-2943-6847
Bailey SpellmanDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0009-0000-1711-1768
Kelsey WigandDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0009-0009-3675-8722
Matyas SandorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-6463-6807
Zsuzsanna FabryDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0003-4555-9732

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
NEUROSCIENCE TRAINING PROGRAMT32GM007507 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HALLORAN, MARY C · 1985 to 2017
$9.3M
Neuroscience Training ProgramT32NS105602 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Ari Rosenberg · 2019 to 2026
$2.5M
The role of lymphatic clearance in brain TBR01NS123449 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Matyas Sandor · 2022 to 2026
$2.0M
Neuroinflammation-induced lymphangiogenesis in the CNSR01NS108497 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI FABRY, ZSUZSANNA · 2018 to 2022
$1.9M
Innate immunity of granulomatous inflammation: the role of VEGFR01HL128778 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SANDOR, MATYAS · 2016 to 2019
$1.5M
Role of T cells in ischemic brain damageR01NS103506 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI FABRY, ZSUZSANNA · 2018 to 2021
$1.3M
Innate immunity of granulomatous inflammation: the role of VEGFR56HL128778 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SANDOR, MATYAS · 2015 to 2015
$383k
American Heart Association 915125NCI NIH HHS P30 CA014520Neuroscience Training Program T32-NS105602NHLBI NIH HHS R01 HL128778NHLBI NIH HHS R56 HL128778NIGMS NIH HHS T32 GM007507NIH HHS NS108497NINDS NIH HHS R01 NS103506NINDS NIH HHS R01 NS108497NINDS NIH HHS R01 NS123449NINDS NIH HHS T32 NS105602University of Wisconsin Carbone Cancer Center P30CA014520
6 · The paper itself

Abstract

Cerebrospinal fluid (CSF), antigens, and antigen-presenting cells drain from the central nervous system (CNS) into lymphatic vessels near the cribriform plate and dura, yet the role of these vessels during stroke is unclear. Using a mouse model of ischemic stroke, transient middle cerebral artery occlusion (tMCAO), we demonstrate stroke-induced lymphangiogenesis near the cribriform plate, peaking at day 7 and regressing by day 14. Lymphangiogenesis is restricted to the cribriform plate and deep cervical lymph nodes and is regulated by VEGF-C/VEGFR-3 signaling. The use of a VEGFR-3 inhibitor prevented lymphangiogenesis and led to improved stroke outcomes at earlier time points, with no effects at later time points. VEGF-C delivery after tMCAO did not further increase post-stroke lymphangiogenesis, but instead induced larger brain infarcts. Our data support the damaging role of VEGF-C acutely and a pro-angiogenic role chronically. This nuanced understanding of VEGFR-3 and VEGF-C in stroke pathology advises caution regarding therapeutic VEGF-C use in stroke.

Indexed as

LymphangiogenesisMice, Inbred C57BLStrokeVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3AnimalsDisease Models, AnimalInfarction, Middle Cerebral ArteryLymphatic VesselsMaleMiceRecovery of FunctionSignal TransductionVascular Endothelial Growth Factor Cvascular endothelial growth factor C, mouseVascular Endothelial Growth Factor Receptor-3

Identifiers

PMID39665829
PMCPMC11636551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.